期刊文献+

Na^(18)F用于肿瘤骨转移病灶显像及其诊断效能 被引量:4

The diagnostic value of Na^(18)F PET/CT imaging in bone metastasis
下载PDF
导出
摘要 目的介绍骨转移瘤的Na18F PET/CT显像,并比较其与Na18F PET和99Tcm-亚甲基二膦酸盐(MDP)ECT显像对骨转移病灶的诊断效能。方法对临床15例多发性骨转移瘤患者,分别行Na18F PET/CT、Na18F PET和99Tcm-MDP ECT显像,将肉眼可见的骨骼热区记为转移、无法定性和非转移病灶,通过临床随访最终定性诊断为转移病灶、非转移病灶,比较3种检查方法探测骨转移灶的灵敏度、特异度和准确率。结果 Na18F PET/CT和Na18F PET均检出全部168处病灶,99Tcm-MDP ECT探测到全部病灶的64.88%(109/168)。当无法定性的病灶被计入转移病灶时,Na18F PET/CT、Na18F PET和99Tcm-MDP ECT的灵敏度、特异度分别为100%、100%;99.17%、72.92%;66.67%、39.58%。前两者与后者之间差异均有统计学意义(χ2=17.8、χ2=8.2、χ2=18.0、χ2=25.4,P均<0.05)。当无法定性的病灶被计入非转移病灶时,Na18F PET/CT、Na18F PET和99Tcm-MDP ECT的灵敏度、特异度分别为100%、93.75%;93.33%、79.17%;57.50%、81.25%。PET/CT、PET较ECT灵敏度差异均有统计学意义(χ2=26.1、χ2=22.5,P均<0.05),而特异度差异均无统计学意义(χ2=4.8、χ2=0.44,P均>0.05)。结论 Na18F PET/CT用于骨转移瘤显像具有高灵敏度、高特异度兼备的优势。 Objective To evaluate the diagnostic value of 18F-fluoride(Na18F) PET/CT in bone metastasis and compare with the Na18F PET and 99Tcm-methylene diphosphonate(MDP) ECT.Methods In the prospective study,Na18F PET/CT,Na18F PET and 99Tcm-MDP ECT were performed in 15 patients with multiple metastatic lesions.Lesions were interpreted as normal,equivocal and malignant according to the clinical follow-up results.Results 168 lesions with increased uptake of Na18F were assessed as malignant(n=120,71.43%),benign(n=48,28.57%).99Tcm-MDP ECT identified 64.88% lesions(109/168) and 35.12% lesions(59/168) were overlooked with normal appearance.When equivocal results were considered as positive for malignancy,the sensitivity and specificity of Na18F PET/CT,Na18F PET and 99Tcm-MDP ECT were 100%,100%;99.17%,72.92%;66.67%,39.58% respectively.The statistical differences between the former 2 and the latter were significant(χ2=17.8,χ2=8.2,χ2=18.0,χ2=25.4,P0.05).When equivocal results were considered as negative for malignancy,the sensitivity and specificity of Na18F PET/CT,Na18F PET and 99Tcm-MDP ECT were 100%,93.75%;93.33%,79.17%;57.50%,81.25% respectively.There were significant differences in sensitivity between Na18F PET/CT,Na18F PET and 99Tcm-MDP ECT(χ2=26.1,χ2=22.5,P0.05),while there were no significant differences in specificity among them(χ2=4.8,χ2=0.44,P0.05).Conclusion Na18F PET/CT is a higher sensitive and specific modality for detection of bone metastases.
出处 《上海医学影像》 2012年第3期173-178,共6页 Shanghai Medical Imaging
关键词 肿瘤转移 骨疾病 18F离子 体层摄影术 发射型计算机 99Tcm-亚甲基二膦酸盐 Neoplasm metastasis Bone disease 18F-Fluoride Tomography emission-computed 99Tcm-methylene diphosphonate
  • 相关文献

参考文献11

  • 1BLAU M, NAGLER W, BENDER. M A, et al. Fluo- rine-18: a new isotope for bone scanning [J]. J Nucl Med, 1962, 3: 332-334.
  • 2EVEN-SAPIR E, METSER U, MISHANI E, et al. The detection of bone metastases in patients with high-risk prostate cancer: ^99Tc^m-MDP planar bone scintigraphy, single-and multi-field-of-view SPECT, ^18F-fluoride PET, and ^18F-fluoride PET/CT [J]. J Nucl Med, 2006, 47(2): 287-297.
  • 3KRUGER S, BUCK A K, MOTTAGHY F M, et al. De- tection of bone metastases in patients with lung cancer: ^99Tc^m-MDP planar bone scintigraphy, ^18F-fluoride PET or ^18F-FDG PET/CT [J]. EurJ Nucl Med Mol Imaging, 2009, 36(11): 1807-1812.
  • 4EVEN-SAPIR E, METSER U, FLUSSER G, et al. As- sessment of malignant skeletal disease: initial experience with ^18F-fluoride PET/CT and comparison between ^18F-fluoride PET and ^18F-fluoride PET/CT[J]. J Nucl Med, 2004, 45(2): 272-278.
  • 5LIM R, FAHEY F H, DRUBACH L A, et al. Early expe- rience with ^18F sodium fluoride bone PET in young patients with back pain [J]. J Pediatr Orthop, 2007, 27(3): 277-282.
  • 6HOCKLEY G B, SCOTT J H, PETER J, et al. An automatedmethod for preparation of [^18F]sodium fluoride for injection,USP to address the technetium-^99m isotope shortage [J].Appllkadiatlsot, 2010, 68(1): 117-119.
  • 7李伟,屈婉莹,李威,韩丽君,于治国,姚稚明.SPECT/CT骨显像鉴别诊断脊柱良恶性病变的价值[J].中华核医学杂志,2002,22(6):343-345. 被引量:81
  • 8WOOTTON R., DOFkE C. The single-passage extractionof ^18F in rabbit bone [J]. ClinPhysPhysiolMeas, 1986, 7(4):333-343.
  • 9BLAKE G M, PARK HOLOHAN S J, COOK G J, et al.Quantitative studies of bone with the use of ^18F-fluorideand ^99Tcm-methylene diphosphonate [J]. SeminNucl Med,2001, 31(1):28-49.
  • 10吴书其,刘建军,宋少莉,陈涛,顾平,潘玲玲,万良荣,黄钢.骨转移瘤18F—FDGPET/CT影像学表现分析[J].中华核医学杂志,2010,30(2):94-97. 被引量:4

二级参考文献15

  • 1李林,赵祯,郭兴.恶性肿瘤骨转移影像学诊断[J].中华核医学杂志,2006,26(5):315-318. 被引量:57
  • 2Nakai T,Okuyama C,Kubota T,et al.Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer.Eur J Nucl Med Mol Imaging,2005,32:1253-1258.
  • 3Nakamoto Y,Cohade C,Tatsumi M,et al.CT appearance of bone metastases detected with FDG PET as part of the same PET/CT examination.Radiology,2005,237:627-634.
  • 4Even-Sapir E,Metser U,Mishani E,et al.The detection of bone metastases in patients with high-risk prostate cancer:^99Tc^m-MDP planar bone scintigraphy,single-and muti-field-of view SPECT,^18F-fluoride PET and ^18F-fluoride PET/CT.J Nucl Med,2006,47:287-297.
  • 5Taira AV,Herfkens RJ,Gambhir SS,et al.Detection of bone metastases:assessment of integrated FDG PET/CT imaging.Radiology,2007,243:204-211.
  • 6Choong PF.The molecular basis of skeletal metastases.Clin Orthop Relat Res,2003,415 Suppl:S19-S31.
  • 7Blake GM,Park-Holohan SJ,Cook GJ,et al.Quantitative studies of bone with the use of ^18F-fluoride and ^99Tc^m-methylene diphosphonate.Semin Nucl Med,2001,31:28-49.
  • 8Israel O,Goldberg A,Nachtigal A,et al.FDG-PET and CT patterns of bone metastases and their relationship to previously administered anti-cancer therapy.Eur J Nucl Med Mol Imaging,2006,33:1280-1284.
  • 9Du Y,Cullum I,Illidge TM,et al.Fusion of metabolic function and morphology:sequential ^18F-fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.J Clin Oncol,2007,25:1-9.
  • 10Wagnar HN. Highlights 2001 lecture: against all odds, nuclear medicine has thrived. J Nucl Med,2001,42:12N-30N.

共引文献83

同被引文献31

  • 1李彩云,龚谋春,潘建虎.卵巢癌二次探查手术前PET-CT检查的作用及临床意义[J].东南国防医药,2013,15(2):141-143. 被引量:2
  • 2李彦生,王俊起,刘磊,高硕.^(18)F—NaF的合成及其在肺癌骨转移中的临床应用[J].中华核医学杂志,2006,26(1):18-20. 被引量:8
  • 3王俊起,高硕.PET评价骨转移瘤[J].国际放射医学核医学杂志,2006,30(2):87-90. 被引量:6
  • 4Kruger S,Buck AK,Mottaghy FM,et al.Detection of bone metastases in patients with lung cancer:99mTc-MDP planar bone scintigraphy,18F-fluoride PET or18F-FDG PET/CT[J].Eur J Nucl Med Mol Imaging,2009,11(36):1807-1812.
  • 5Petersen H,Ogren M,Hoilund-Carlsen PF.Fluoride-positron emission tomography/computed tomography for differential diagnosis in suspected bone metastasis[J].Ugeskr Laeger,2010,172(20):1538-1539.
  • 6Aparici CM,Win AZ.Use of Na18F positron emission tomography/ computed tomography in the detection of bone metastasis from papillary renal cell carcinoma[J].World J Nucl Med,2014,13(2):135-137.
  • 7Tateishi U,Morita S,Taguri M,et al.A meta-analysis of18F-Fluoride positron emission tomography for assessment of metastatic bone tumor[J].Ann Nucl Med,2010,24(7):523-531.
  • 8Lim R,Fahey FH,Drubach LA,et al.Early experience with 18fluorine sodium fluoride bone PET in young patients with back pain[J].J Pediatr Orthop,2007,27(3):277-282.
  • 9Blake GM,Park-Holohan S J,Cook GJ,et al.Quantitative studies of bone with the use of 18F-fluoride and 99Tcm-methylene diphosphonate[J].SeminNucl Med,2001,31(11):28-49.
  • 10Ullmark G,Sorensen J,Nilsson O,et al.Analysis of bone formation on porous and calcium phosphate-coated acetabular cups:a randomized clinical 18fluoride study[J].Hip Int,2012,22(2):172-178.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部